(VIRP) Virbac - Performance -6.4% in 12m

VIRP performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.

Performance Rating 15.84%
#47 in Peer-Group
Rel. Strength 34.21%
#5005 in Stock-Universe
Total Return 12m -6.39%
#94 in Peer-Group
Total Return 5y 76.95%
#22 in Peer-Group
P/E Value
P/E Trailing 18.5
P/E Forward -
High / Low EUR
52 Week High 400.00 EUR
52 Week Low 280.60 EUR
Sentiment Value
VRO Trend Strength +-100 44.37
Buy/Sell Signal +-5 1.54
Support / Resistance Levels
Support
Resistance
12m Total Return: VIRP (-6.4%) vs XLV (-5.1%)
Total Return of Virbac versus its related sector ETF XLV
5y Drawdown (Underwater) Chart
5 Year Drawdown / Underwater Chart for (VIRP) Virbac - Performance -6.4% in 12m

Top Performer in Pharmaceuticals

Short Term Performance

Symbol 1w 1m 3m
VIRP -2.45% 4.09% -1.4%
PHAT 20.5% 206% 120%
VTYX 0.0% 112% 81.6%
ALTS 3.27% 64.1% 127%

Long Term Performance

Symbol 6m 12m 5y
VIRP 0.47% -6.39% 77%
ALTS 172% 335% 234%
VRNA 116% 453% 1,673%
BGM 57.0% 276% -72.2%

Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating

Symbol 1m 12m 5y P/E P/E Forward PEG EPS Stability EPS CAGR
CORT NASDAQ
Corcept Therapeutics
-4.5% 145% 360% 61.3 55.3 0.61 23.7% -5.15%
LLY NYSE
Eli Lilly
12% -6.78% 514% 66.1 37 1.24 58.2% 18.9%
NVS NYSE
Novartis
10.1% 17.9% 81.6% 18.5 14 1.37 8.70% 9.2%
NOVN SW
Novartis
7.55% 7.58% 54.8% 18.7 14.1 1.38 9.80% 11.2%
SFZN SW
Siegfried Holding
-0.63% 2.28% 140% 26.1 25 1.48 77.8% 77.6%
GSK NYSE
GlaxoSmithKline
10% 4.92% 57.7% 19.9 9.2 0.4 -25.2% 3.11%
AZN NASDAQ
AstraZeneca
9.51% -4.27% 58.6% 28.9 15.9 0.96 52.7% 22.3%
IPN PA
Ipsen
2.14% -13% 54.2% 24.4 10.3 0.74 -6.40% -6.33%

Performance Comparison: VIRP vs XLV vs S&P 500

XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for VIRP
Total Return (including Dividends) VIRP XLV S&P 500
1 Month 4.09% 4.35% 1.11%
3 Months -1.40% -6.89% 5.58%
12 Months -6.39% -5.08% 10.51%
5 Years 76.95% 50.53% 109.12%

Trend Score (consistency of price movement) VIRP XLV S&P 500
1 Month 52.7% 65.8% 69.9%
3 Months 69.8% -72% 69.3%
12 Months -75.8% -62.2% 43.2%
5 Years 37.1% 88.5% 84.1%

Relative Strength (compared with Indexes) Rank in Peer Group vs. XLV vs. S&P 500
1 Month #98 -0.24% 2.95%
3 Month #93 5.90% -6.61%
12 Month #94 -1.38% -15.29%
5 Years #24 17.55% -15.38%

FAQs

Does Virbac (VIRP) outperform the market?

No, over the last 12 months VIRP made -6.39%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.08%. Over the last 3 months VIRP made -1.40%, while XLV made -6.89%.

Performance Comparison VIRP vs Indeces and Sectors

Above 0 means better perfomance compared to Symbol in this Timeframe

VIRP vs. Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY -2% 3% 1.5% -17%
US NASDAQ 100 QQQ -1.8% 2.6% 2.3% -16%
German DAX 40 DAX 0.2% 4.8% -14.9% -36%
Shanghai Shenzhen CSI 300 CSI 300 -1.7% 5% -0.4% -18%
Hongkong Hang Seng HSI -2.5% -1% -17.6% -34%
India NIFTY 50 INDA -0.3% 5.4% 2.5% -5%
Brasil Bovespa EWZ -4.3% 3.6% -18.7% -16%

VIRP vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC -1.7% 2.6% -1.3% -29%
Consumer Discretionary XLY -1.5% 5.9% 11.3% -24%
Consumer Staples XLP -1.7% 4.3% -0% -13%
Energy XLE -7.9% 1.2% -2.1% -9%
Financial XLF -0.4% 6.7% -1.4% -30%
Health Care XLV -3.9% -0.3% 1.9% -1%
Industrial XLI -1% 3.8% -4.1% -25%
Materials XLB -1.3% 2.7% 0.7% -6%
Real Estate XLRE -2.5% 3.1% 0.5% -19%
Technology XLK -2.3% 2.1% 1.1% -11%
Utilities XLU -3.4% 3.6% -6.9% -28%
Aerospace & Defense XAR -1% -1.7% -15.5% -49%
Biotech XBI -1.7% -3.7% 12.2% 1%
Homebuilder XHB -0.4% 9.1% 16.9% 3%
Retail XRT 1.9% 4.3% 9.4% -7%

VIRP vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO -13.8% -14.6% -8.38% -10%
Natural Gas UNG -1.2% 6.7% -16.8% 8%
Gold GLD -5.6% -2.1% -28.7% -54%
Silver SLV -1.2% -7.3% -18.1% -29%
Copper CPER 0.5% 2.4% -13.4% -15%

VIRP vs. Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT -3.5% 3.4% 2.9% -2%
iShares High Yield Corp. Bond HYG -2.5% 3.6% -2.2% -16%